HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides.

Abstract
Recently, attention has been focused on pharmacological treatments that increase HDL cholesterol to prevent coronary artery disease. Despite three decades of extensive research of human apolipoprotein A-I (apoA-I), the major protein component of HDL, the molecular basis for its antiatherogenic and anti-inflammatory functions remain elusive. Another protein component of HDL, apoA-II, has structural features similar to those of apoA-I but does not possess atheroprotective properties. To understand the molecular basis for the effectiveness of apoA-I, we used model synthetic peptides. We designed analogs of the class A amphipathic helical motif in apoA-I that is responsible for solubilizing phospholipids. None of these analogs has sequence homology to apoA-I, but all are similar in their lipid-associating structural motifs. Although all of these peptide analogs interact with phospholipids to form peptide:lipid complexes, the biological properties of these analogs are different. Physical-chemical and NMR studies of these peptides have enabled the delineation of structural requirements for atheroprotective and anti-inflammatory properties in these peptides. It has been shown that peptides that interact strongly with lipid acyl chains do not have antiatherogenic and anti-inflammatory properties. In contrast, peptides that associate close to the lipid head group (and hence do not interact strongly with the lipid acyl chain) are antiatherogenic and anti-inflammatory. Understanding the structure and function of apoA-I and HDL through studies of the amphipathic helix motif may lead to peptide-based therapies for inhibiting atherosclerosis and other related inflammatory lipid disorders.
AuthorsG M Anantharamaiah, Vinod K Mishra, David W Garber, Geeta Datta, Shaila P Handattu, Mayakonda N Palgunachari, Manjula Chaddha, Mohamad Navab, Srinivasa T Reddy, Jere P Segrest, Alan M Fogelman
JournalJournal of lipid research (J Lipid Res) Vol. 48 Issue 9 Pg. 1915-23 (Sep 2007) ISSN: 0022-2275 [Print] United States
PMID17570869 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Anti-Inflammatory Agents
  • Antioxidants
  • Apolipoprotein A-I
  • Apolipoproteins A
  • Cholesterol, HDL
Topics
  • Animals
  • Anti-Inflammatory Agents (therapeutic use)
  • Antioxidants (therapeutic use)
  • Apolipoprotein A-I (chemistry, therapeutic use)
  • Apolipoproteins A (therapeutic use)
  • Atherosclerosis (drug therapy)
  • Biomimetic Materials (therapeutic use)
  • Cholesterol, HDL (physiology)
  • Humans
  • Models, Molecular
  • Protein Structure, Secondary
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: